世界の組換えヒトインスリン産業調査2019-2025

• 英文タイトル：Global Recombinant Human Insulin Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

• レポートコード：QYR9NV16911
• 出版社/出版日：QYResearch / 2019年11月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、115ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界の組換えヒトインスリン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えヒトインスリンの種類別には、に、用途別には、1型糖尿病、2型糖尿病に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・組換えヒトインスリンの種類別市場規模：
・組換えヒトインスリンの用途別市場規模：1型糖尿病、2型糖尿病
・組換えヒトインスリンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Akron Biotech、Wockhardt、Dance Biopharm、Novo Nordisk、Gan & Lee、United Laboratories、Dongbro Pharmaceuticri
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

Insulin is a well-characterized peptide that can be produced byrecombinant DNA technology for human therapeutic use.In 2018, the global Recombinant Human Insulin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Recombinant Human Insulin.

This study researches the market size of Recombinant Human Insulin, presents the global Recombinant Human Insulin sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Recombinant Human Insulin in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Recombinant Human Insulin for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Wockhardt
Dance Biopharm
Novo Nordisk
Gan & Lee
United Laboratories
Dongbro Pharmaceuticri
…

Market Segment by Product Type
Type I
Type II

Market Segment by Application
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Recombinant Human Insulin status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Recombinant Human Insulin manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Human Insulin are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Recombinant Human Insulin Market Size Growth Rate by Type
1.3.2 Type I
1.3.3 Type II
1.4 Market Segment by Application
1.4.1 Global Recombinant Human Insulin Market Share by Application (2019-2025)
1.4.2 Type 1 Diabetes Mellitus
1.4.3 Type 2 Diabetes Mellitus
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Recombinant Human Insulin Market Size
2.1.1 Global Recombinant Human Insulin Revenue 2014-2025
2.1.2 Global Recombinant Human Insulin Sales 2014-2025
2.2 Recombinant Human Insulin Growth Rate by Regions
2.2.1 Global Recombinant Human Insulin Sales by Regions 2014-2019
2.2.2 Global Recombinant Human Insulin Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Recombinant Human Insulin Sales by Manufacturers
3.1.1 Recombinant Human Insulin Sales by Manufacturers 2014-2019
3.1.2 Recombinant Human Insulin Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Recombinant Human Insulin Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Human Insulin Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Recombinant Human Insulin Market Concentration Ratio (CR5 and HHI)
3.3 Recombinant Human Insulin Price by Manufacturers
3.4 Key Manufacturers Recombinant Human Insulin Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Recombinant Human Insulin Market
3.6 Key Manufacturers Recombinant Human Insulin Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 by Recombinant DNA Technology Using Fermentation in Bacteria Way Sales and Revenue (2014-2019)
4.1.2 by Recombinant DNA Technology Using Fermentation in Yeast Way Sales and Revenue (2014-2019)
4.2 Global Recombinant Human Insulin Sales Market Share by Type
4.3 Global Recombinant Human Insulin Revenue Market Share by Type
4.4 Recombinant Human Insulin Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Recombinant Human Insulin Sales by Application

6 North America
6.1 North America Recombinant Human Insulin Breakdown Data by Company
6.2 North America Recombinant Human Insulin Breakdown Data by Type
6.3 North America Recombinant Human Insulin Breakdown Data by Application
6.4 North America Recombinant Human Insulin Breakdown Data by Countries
6.4.1 North America Recombinant Human Insulin Sales by Countries
6.4.2 North America Recombinant Human Insulin Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Recombinant Human Insulin Breakdown Data by Company
7.2 Europe Recombinant Human Insulin Breakdown Data by Type
7.3 Europe Recombinant Human Insulin Breakdown Data by Application
7.4 Europe Recombinant Human Insulin Breakdown Data by Countries
7.4.1 Europe Recombinant Human Insulin Sales by Countries
7.4.2 Europe Recombinant Human Insulin Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Recombinant Human Insulin Breakdown Data by Company
8.2 Asia Pacific Recombinant Human Insulin Breakdown Data by Type
8.3 Asia Pacific Recombinant Human Insulin Breakdown Data by Application
8.4 Asia Pacific Recombinant Human Insulin Breakdown Data by Regions
8.4.1 Asia Pacific Recombinant Human Insulin Sales by Countries
8.4.2 Asia Pacific Recombinant Human Insulin Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Recombinant Human Insulin Breakdown Data by Company
9.2 Central & South America Recombinant Human Insulin Breakdown Data by Type
9.3 Central & South America Recombinant Human Insulin Breakdown Data by Application
9.4 Central & South America Recombinant Human Insulin Breakdown Data by Countries
9.4.1 Central & South America Recombinant Human Insulin Sales by Countries
9.4.2 Central & South America Recombinant Human Insulin Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Insulin Breakdown Data by Type
10.2 Middle East and Africa Recombinant Human Insulin Breakdown Data by Application
10.3 Middle East and Africa Recombinant Human Insulin Breakdown Data by Countries
10.3.1 Middle East and Africa Recombinant Human Insulin Sales by Countries
10.3.2 Middle East and Africa Recombinant Human Insulin Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.1.4 Recombinant Human Insulin Product Introduction
11.1.5 Akron Biotech Recent Development
11.2 Wockhardt
11.2.1 Wockhardt Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.2.4 Recombinant Human Insulin Product Introduction
11.2.5 Wockhardt Recent Development
11.3 Dance Biopharm
11.3.1 Dance Biopharm Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.3.4 Recombinant Human Insulin Product Introduction
11.3.5 Dance Biopharm Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.4.4 Recombinant Human Insulin Product Introduction
11.4.5 Novo Nordisk Recent Development
11.5 Gan & Lee
11.5.1 Gan & Lee Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.5.4 Recombinant Human Insulin Product Introduction
11.5.5 Gan & Lee Recent Development
11.6 United Laboratories
11.6.1 United Laboratories Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.6.4 Recombinant Human Insulin Product Introduction
11.6.5 United Laboratories Recent Development
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Recombinant Human Insulin
11.7.4 Recombinant Human Insulin Product Introduction
11.7.5 Dongbro Pharmaceuticri Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Recombinant Human Insulin Sales Channels
12.2.2 Recombinant Human Insulin Distributors
12.3 Recombinant Human Insulin Customers

13 Market Forecast
13.1 Global Recombinant Human Insulin Sales and Revenue Forecast 2019-2025
13.2 Global Recombinant Human Insulin Sales Forecast by Type
13.3 Global Recombinant Human Insulin Sales Forecast by Application
13.4 Recombinant Human Insulin Forecast by Regions
13.4.1 Global Recombinant Human Insulin Sales Forecast by Regions 2019-2025
13.4.2 Global Recombinant Human Insulin Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Recombinant Human Insulin Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Recombinant Human Insulin Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Recombinant Human Insulin Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Recombinant Human Insulin Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Recombinant Human Insulin Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Recombinant Human Insulin Product Picture
Table Recombinant Human Insulin Key Market Segments
Table Major Manufacturers Recombinant Human Insulin Covered in This Report
Table Global Recombinant Human Insulin Market Size Growth Rate by Type 2019-2025 (g) & (Million US$)
Figure Global Recombinant Human Insulin Sales Market Shar by Type 2014-2025
Table Global Recombinant Human Insulin Market Share by Application 2019-2025 (g)
Figure Type 1 Diabetes Mellitus Use Case
Figure Type 2 Diabetes Mellitus Use Case
Figure Recombinant Human Insulin Report Years Considered
Figure Global Recombinant Human Insulin Market Size 2014-2025 (Million US$)
Figure Global Recombinant Human Insulin Sales 2014-2019 (g)
Table Global Recombinant Human Insulin Market Size by Regions 2014-2019 (g) & (Million US$)
Table Global Recombinant Human Insulin Sales by Regions 2014-2019 (g)
Table Global Recombinant Human Insulin Sales Market Share by Regions 2014-2019
Figure Global Recombinant Human Insulin Sales Market Share by Regions 2014-2019
Figure Global Recombinant Human Insulin Sales Market Share by Regions in 2018
Table Global Recombinant Human Insulin Revenue by Regions 2014-2019 (Million US$)
Table Global Recombinant Human Insulin Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Human Insulin Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Human Insulin Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Recombinant Human Insulin Sales by Manufacturers (2014-2019) (g)
Table Global Recombinant Human Insulin Sales Share by Manufacturers (2014-2019)
Figure Global Recombinant Human Insulin Sales Share by Manufacturers in 2018
Table Recombinant Human Insulin Revenue by Manufacturers (2014-2019) (Million USD)
Table Recombinant Human Insulin Revenue Share by Manufacturers (2014-2019)
Figure Recombinant Human Insulin Value Share by Manufacturers in 2018
Table Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Recombinant Human Insulin Price (2014-2019) (USD/mg)
Table Key Manufacturers Recombinant Human Insulin Plants/Factories Distribution
Table Key Manufacturers Recombinant Human Insulin Area Served
Table Date of Key Manufacturers Enter into Recombinant Human Insulin Market
Table Key Manufacturers Recombinant Human Insulin Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global by Recombinant DNA Technology Using Fermentation in Bacteria Way Sales an目录输出!D Revenue (2014-2019) (g) & (Million US$)
Table Global by Recombinant DNA Technology Using Fermentation in Yeast Way Sales an目录输出!D Revenue (2014-2019) (g) & (Million US$)
Table Global Recombinant Human Insulin Sales by Type (2014-2019) (g)
Table Global Recombinant Human Insulin Sales Share by Type (2014-2019)
Figure Global Recombinant Human Insulin Sales Market Share by Type (2014-2019)
Figure Global Recombinant Human Insulin Sales Market Share by Type in 2018
Table Global Recombinant Human Insulin Revenue by Type (2014-2019) (Million US$)
Table Global Recombinant Human Insulin Revenue Share by Type (2014-2019)
Figure Global Recombinant Human Insulin Revenue Market Share by Type (2014-2019)
Figure Global Recombinant Human Insulin Revenue Market Share by Type in 2018
Table Recombinant Human Insulin Price by Type 2014-2019 (USD/mg)
Table Global Recombinant Human Insulin Sales by Application (2014-2019) (g)
Table Global Recombinant Human Insulin Sales Share by Application (2014-2019)
Figure Global Sales Recombinant Human Insulin Market Share by Application (2014-2019)
Figure Global Sales Recombinant Human Insulin Market Share by Application in 2018
Figure North America Recombinant Human Insulin Sales Growth Rate 2014-2019 (g)
Figure North America Recombinant Human Insulin Revenue Growth Rate 2014-2019 (Million US$)
Table North America Recombinant Human Insulin Sales by Company (2014-2019) (g)
Table North America Recombinant Human Insulin Sales Market Share by Company (2014-2019)
Figure North America Recombinant Human Insulin Sales Market Share by Company in 2018
Table North America Recombinant Human Insulin Sales by Type (2014-2019) (g)
Table North America Recombinant Human Insulin Sales Market Share by Type (2014-2019)
Figure North America Recombinant Human Insulin Market Share by Type in 2018
Table North America Recombinant Human Insulin Sales by Application (2014-2019) (g)
Table North America Recombinant Human Insulin Sales Market Share by Application (2014-2019)
Figure North America Recombinant Human Insulin Market Share by Application in 2018
Table North America Recombinant Human Insulin Sales by Countries (2014-2019) (g)
Table North America Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Human Insulin Sales Market Share by Countries in 2018
Table North America Recombinant Human Insulin Revenue by Countries (2014-2019) (Million US$)
Table North America Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure United States Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Canada Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Mexico Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Europe Recombinant Human Insulin Sales Growth Rate 2014-2019 (g)
Figure Europe Recombinant Human Insulin Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Recombinant Human Insulin Sales by Company (2014-2019) (g)
Table Europe Recombinant Human Insulin Sales Market Share by Company (2014-2019)
Figure Europe Recombinant Human Insulin Sales Market Share by Company in 2018
Table Europe Recombinant Human Insulin Sales by Type (2014-2019) (g)
Table Europe Recombinant Human Insulin Sales Market Share by Type (2014-2019)
Figure Europe Recombinant Human Insulin Sales Market Share by Type in 2018
Table Europe Recombinant Human Insulin Sales by Application (2014-2019) (g)
Table Europe Recombinant Human Insulin Sales Market Share by Application (2014-2019)
Figure Europe Recombinant Human Insulin Sales Market Share by Application in 2018
Table Europe Recombinant Human Insulin Sales by Countries (2014-2019) (g)
Table Europe Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure Europe Recombinant Human Insulin Sales Market Share by Countries in 2018
Table Europe Recombinant Human Insulin Revenue by Countries (2014-2019) (Million US$)
Table Europe Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure Europe Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure Germany Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure France Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure UK Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Italy Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Russia Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Asia Pacific Recombinant Human Insulin Sales Growth Rate 2014-2019 (g)
Figure Asia Pacific Recombinant Human Insulin Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Recombinant Human Insulin Sales by Regions (2014-2019) (g)
Table Asia Pacific Recombinant Human Insulin Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Recombinant Human Insulin Sales Market Share by Regions in 2018
Table Asia Pacific Recombinant Human Insulin Sales by Type (2014-2019) (g)
Table Asia Pacific Recombinant Human Insulin Sales Market Share by Type (2014-2019)
Figure Asia Pacific Recombinant Human Insulin Market Share by Type in 2018
Table Asia Pacific Recombinant Human Insulin Sales by Application (2014-2019) (g)
Table Asia Pacific Recombinant Human Insulin Sales Market Share by Application (2014-2019)
Figure Asia Pacific Recombinant Human Insulin Market Share by Application in 2018
Table Asia Pacific Recombinant Human Insulin Sales by Countries (2014-2019) (g)
Table Asia Pacific Recombinant Human Insulin Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Recombinant Human Insulin Sales Market Share by Regions in 2018
Table Asia Pacific Recombinant Human Insulin Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Recombinant Human Insulin Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Recombinant Human Insulin Revenue Market Share by Regions in 2018
Figure China Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure China Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Japan Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Korea Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure India Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure India Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Australia Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Indonesia Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Malaysia Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Philippines Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Thailand Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Vietnam Recombinant Human Insulin Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Recombinant Human Insulin Sales Growth Rate 2014-2019 (g)
Figure Central & South America Recombinant Human Insulin Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Recombinant Human Insulin Sales by Company (2014-2019) (g)
Table Central & South America Recombinant Human Insulin Sales Market Share by Company (2014-2019)
Figure Central & South America Recombinant Human Insulin Sales Market Share by Company in 2018
Table Central & South America Recombinant Human Insulin Sales by Type (2014-2019) (g)
Table Central & South America Recombinant Human Insulin Sales Market Share by Type (2014-2019)
Figure Central & South America Recombinant Human Insulin Market Share by Type in 2018
Table Central & South America Recombinant Human Insulin Sales by Application (2014-2019) (g)
Table Central & South America Recombinant Human Insulin Sales Market Share by Application (2014-2019)
Figure Central & South America Recombinant Human Insulin Market Share by Application in 2018
Table Central & South America Recombinant Human Insulin Sales by Countries (2014-2019) (g)
Table Central & South America Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure Central & South America Recombinant Human Insulin Sales Market Share by Countries in 2018
Table Central & South America Recombinant Human Insulin Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure Central & South America Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Brazil Recombinant Human Insulin Revenue Growth Rate (2014-2019) (g)
Figure Middle East and Africa Recombinant Human Insulin Sales Growth Rate 2014-2019 (g)
Figure Middle East and Africa Recombinant Human Insulin Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Recombinant Human Insulin Sales by Type (2014-2019) (g)
Table Middle East and Africa Recombinant Human Insulin Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Sales Market Share by Type in 2018
Table Middle East and Africa Recombinant Human Insulin Sales by Application (2014-2019) (g)
Table Middle East and Africa Recombinant Human Insulin Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Sales Market Share by Application in 2018
Table Middle East and Africa Recombinant Human Insulin Sales by Countries (2014-2019) (g)
Table Middle East and Africa Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Sales Market Share by Countries in 2018
Table Middle East and Africa Recombinant Human Insulin Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure GCC Countries Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure GCC Countries Recombinant Human Insulin Revenue Growth Rate (2014-2019) (g)
Figure Egypt Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure Egypt Recombinant Human Insulin Revenue Growth Rate (2014-2019) (g)
Figure South Africa Recombinant Human Insulin Sales Growth Rate (2014-2019) (g)
Figure South Africa Recombinant Human Insulin Revenue Growth Rate (2014-2019) (g)
Table Akron Biotech Company Details
Table Akron Biotech Description and Business Overview
Table Akron Biotech Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table Akron Biotech Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table Akron Biotech Recombinant Human Insulin Sales Market Share in Global Market
Table Akron Biotech Recent Development
Table Wockhardt Company Details
Table Wockhardt Description and Business Overview
Table Wockhardt Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table Wockhardt Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table Wockhardt Recombinant Human Insulin Sales Market Share in Global Market
Table Wockhardt Recent Development
Table Dance Biopharm Company Details
Table Dance Biopharm Description and Business Overview
Table Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table Dance Biopharm Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table Dance Biopharm Recombinant Human Insulin Sales Market Share in Global Market
Table Dance Biopharm Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Description and Business Overview
Table Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table Novo Nordisk Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table Novo Nordisk Recombinant Human Insulin Sales Market Share in Global Market
Table Novo Nordisk Recent Development
Table Gan & Lee Company Details
Table Gan & Lee Description and Business Overview
Table Gan & Lee Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table Gan & Lee Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table Gan & Lee Recombinant Human Insulin Sales Market Share in Global Market
Table Gan & Lee Recent Development
Table United Laboratories Company Details
Table United Laboratories Description and Business Overview
Table United Laboratories Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table United Laboratories Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table United Laboratories Recombinant Human Insulin Sales Market Share in Global Market
Table United Laboratories Recent Development
Table Dongbro Pharmaceuticri Company Details
Table Dongbro Pharmaceuticri Description and Business Overview
Table Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (Million US$), Price (USD/mg) and Gross Margin (2014-2019)
Table Dongbro Pharmaceuticri Recombinant Human Insulin Sales Growth Rate (2014-2019)
Table Dongbro Pharmaceuticri Recombinant Human Insulin Sales Market Share in Global Market
Table Dongbro Pharmaceuticri Recent Development
Figure Recombinant Human Insulin Value Chain
Table Recombinant Human Insulin Distributors List
Table Recombinant Human Insulin Customers List
Table Global Recombinant Human Insulin Sales Forecast 2019-2025 (g) & (Million US$)
Figure Global Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Global Recombinant Human Insulin Revenue Forecast 2019-2025 (Million US$)
Table Global Recombinant Human Insulin Sales Forecast by Type 2019-2025 (g)
Figure Global Recombinant Human Insulin Sales Forecast by Type 2019-2025 (g)
Figure Global Recombinant Human Insulin Sales Market Share Forecast by Type 2019-2025
Table Global Recombinant Human Insulin Sales Forecast by Application 2019-2025 (g)
Figure Global Recombinant Human Insulin Sales Forecast by Application 2019-2025 (g)
Figure Global Recombinant Human Insulin Sales Market Share Forecast by Application 2019-2025
Table Global Recombinant Human Insulin Sales Forecast by Regions 2019-2025 (g)
Figure Global Recombinant Human Insulin Sales Forecast by Regions 2019-2025 (g)
Figure Global Recombinant Human Insulin Sales Market Share Forecast by Regions 2019-2025
Table Global Recombinant Human Insulin Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Recombinant Human Insulin Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Recombinant Human Insulin Revenue Market Share Forecast by Regions 2019-2025
Table North America Recombinant Human Insulin Sales Forecast by Countries 2019-2025 (g)
Table North America Recombinant Human Insulin Sales Market Share Forecast by Countries 2019-2025
Table North America Recombinant Human Insulin Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Recombinant Human Insulin Revenue Market Share Forecast by Countries 2019-2025
Figure United States Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Canada Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Mexico Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Table Europe Recombinant Human Insulin Sales Forecast by Countries 2019-2025 (g)
Table Europe Recombinant Human Insulin Sales Market Share Forecast by Countries 2019-2025
Table Europe Recombinant Human Insulin Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Recombinant Human Insulin Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure France Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure UK Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Italy Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Russia Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Table Asia Pacific Recombinant Human Insulin Sales Forecast by Regions 2019-2025 (g)
Table Asia Pacific Recombinant Human Insulin Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Recombinant Human Insulin Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Recombinant Human Insulin Revenue Market Share Forecast by Regions 2019-2025
Figure China Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Japan Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure South Korea Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure India Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Australia Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Indonesia Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Thailand Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Malaysia Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Philippines Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Vietnam Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Table Central & South America Recombinant Human Insulin Sales Forecast by Countries 2019-2025 (g)
Table Central & South America Recombinant Human Insulin Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Recombinant Human Insulin Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Recombinant Human Insulin Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Table Middle East and Africa Recombinant Human Insulin Sales Forecast by Regions 2019-2025 (g)
Table Middle East and Africa Recombinant Human Insulin Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Recombinant Human Insulin Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Recombinant Human Insulin Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure GCC Countries Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure Egypt Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Figure South Africa Recombinant Human Insulin Sales Forecast 2019-2025 (g)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の組換えヒト成長ホルモン産業調査2019-2025

Global Recombinant Human Growth Hormone Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16910 2019年11月18日 114Pages
※本調査レポートでは、世界の組換えヒト成長ホルモン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えヒト成長ホルモンの種類別には、パウダー、溶剤に、用途別には、成長ホルモン欠乏症（GHD）、ターナー症候群、慢...

組み換えヒトエンドスタチンのグローバル市場調査 2019年

Global Recombinant Human Endostatin Market Professional Survey Report 2019
QYR9NV11071 2019年11月14日 104Pages
※本調査レポートは、組み換えヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグ...

世界の組換えトリプシン液剤産業調査2019-2025

Global Recombinant Trypsin Liquid Solution Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16913 2019年11月18日 113Pages
※本調査レポートでは、世界の組換えトリプシン液剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えトリプシン液剤の種類別には、1X Sulotion、10Xソリューションに、用途別には、インスリン製造、ワクチ...

世界の組換えトリプシンパウダー産業調査2019-2025

Global Recombinant Trypsin Powder Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16914 2019年11月18日 117Pages
※本調査レポートでは、世界の組換えトリプシンパウダー市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えトリプシンパウダーの種類別には、チューブで包装、ボトルで包装に、用途別には、インスリン製造、ワクチン製造、...

世界の組換えタンパク質ワクチン産業調査2019-2025

Global Recombinant Protein Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16912 2019年11月18日 118Pages
※本調査レポートでは、世界の組換えタンパク質ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えタンパク質ワクチンの種類別には、細菌細胞培養、哺乳類細胞培養に、用途別には、人間、動物に、地域別には、北米...

ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025

Global Human DNA Vaccines Market Size, Status and Forecast 2019-2025
QYR9NV18016 2019年11月18日 96Pages
※当調査レポートでは、ヒトDNAワクチンの世界市場について調査・分析し、ヒトDNAワクチンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（組換えタンパク質ワクチン、遺伝子ベースワクチン）、用途別（イ...

組み換えヒトエンドスタチンのグローバル市場調査 2019年 The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global…
世界の組換えヒト成長ホルモン産業調査2019-2025 Recombinant Human Growth Hormone (HGH) is a bioactive protein intended for use in cell culture applications. HGH is a hormone with multiple effects. HGH is a pleiotropic molecule that binds the GH receptor. Recombinant Human Growth Hormone (HGH) is one of our more than 250 available Gibco® recombina…
組換えヒト血清アルブミンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Human serum albumin is the serum albuminfound in human blood. It is the most abundant protein in human blood plasma; it constitutes about half of serum protein. It is produced in the liver. It is soluble and monomeric. Scope of the Report: This report focuses on the Recombinant Human Serum Albumin i…
ヒトインスリンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. Scope of the Report: This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This repo…
組換えペプチドのグローバル市場調査 2019年 The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, th…